Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Mahidol University's Institutional Repository (Mahidol IR)
Simple jQuery Dropdowns
About Us
Ethics
Service
Statistics & Reports
Feedback
Browsing by Author Anna Turkina
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 2 of 2
Issue Date
Title
Author(s)
1-May-2012
Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis
Franck E. Nicolini
;
Tamas Masszi
;
Zhixiang Shen
;
Neil J. Gallagher
;
Saengsuree Jootar
;
Bayard L. Powell
;
Pedro Enrique Dorlhiac-Llacer
;
Ming Zheng
;
Tomasz Szczudlo
;
Anna Turkina
;
Hopital Edouard Herriot
;
Szent Laszlo Hospital
;
Ruijin Hospital
;
Novartis International AG
;
Mahidol University
;
Wake Forest University
;
Universidade de Sao Paulo - USP
;
Novartis Pharmaceuticals Corporation
;
National Research Center for Hematology
1-Jan-2012
Expanding Nilotinib Access in Clinical Trials (ENACT): An open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase
Franck E. Nicolini
;
Anna Turkina
;
Zhi Xiang Shen
;
Neil Gallagher
;
Saengsuree Jootar
;
Bayard L. Powell
;
Carmino De Souza
;
Ming Zheng
;
Tomasz Szczudlo
;
Philipp Le Coutre
;
Hopital Edouard Herriot
;
National Research Center for Hematology
;
Ruijin Hospital
;
Novartis International AG
;
Mahidol University
;
Wake Forest University Baptist Medical Center
;
Universidade Estadual de Campinas
;
Novartis Pharmaceuticals Corporation
;
Charité – Universitätsmedizin Berlin